1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Migraine Headache Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Almotriptan 1.2.3 Eletriptan 1.2.4 Sumatriptan 1.2.5 Rizatriptan 1.2.6 Zolmitriptan 1.2.7 Naratriptan 1.2.8 Frovatriptan 1.2.9 Others 1.3 Market by Application 1.3.1 Global Migraine Headache Drugs Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Acute Migraine 1.3.3 Common Migraine 1.3.4 Classic Migraine 1.3.5 Chronic Migraine 1.3.6 Other Migraines 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Migraine Headache Drugs Market Perspective (2018-2029) 2.2 Migraine Headache Drugs Growth Trends by Region 2.2.1 Global Migraine Headache Drugs Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Migraine Headache Drugs Historic Market Size by Region (2018-2023) 2.2.3 Migraine Headache Drugs Forecasted Market Size by Region (2024-2029) 2.3 Migraine Headache Drugs Market Dynamics 2.3.1 Migraine Headache Drugs Industry Trends 2.3.2 Migraine Headache Drugs Market Drivers 2.3.3 Migraine Headache Drugs Market Challenges 2.3.4 Migraine Headache Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Migraine Headache Drugs Players by Revenue 3.1.1 Global Top Migraine Headache Drugs Players by Revenue (2018-2023) 3.1.2 Global Migraine Headache Drugs Revenue Market Share by Players (2018-2023) 3.2 Global Migraine Headache Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Migraine Headache Drugs Revenue 3.4 Global Migraine Headache Drugs Market Concentration Ratio 3.4.1 Global Migraine Headache Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Migraine Headache Drugs Revenue in 2022 3.5 Migraine Headache Drugs Key Players Head office and Area Served 3.6 Key Players Migraine Headache Drugs Product Solution and Service 3.7 Date of Enter into Migraine Headache Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Migraine Headache Drugs Breakdown Data by Type 4.1 Global Migraine Headache Drugs Historic Market Size by Type (2018-2023) 4.2 Global Migraine Headache Drugs Forecasted Market Size by Type (2024-2029) 5 Migraine Headache Drugs Breakdown Data by Application 5.1 Global Migraine Headache Drugs Historic Market Size by Application (2018-2023) 5.2 Global Migraine Headache Drugs Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Migraine Headache Drugs Market Size (2018-2029) 6.2 North America Migraine Headache Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Migraine Headache Drugs Market Size by Country (2018-2023) 6.4 North America Migraine Headache Drugs Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Migraine Headache Drugs Market Size (2018-2029) 7.2 Europe Migraine Headache Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Migraine Headache Drugs Market Size by Country (2018-2023) 7.4 Europe Migraine Headache Drugs Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Migraine Headache Drugs Market Size (2018-2029) 8.2 Asia-Pacific Migraine Headache Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Migraine Headache Drugs Market Size by Region (2018-2023) 8.4 Asia-Pacific Migraine Headache Drugs Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Migraine Headache Drugs Market Size (2018-2029) 9.2 Latin America Migraine Headache Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Migraine Headache Drugs Market Size by Country (2018-2023) 9.4 Latin America Migraine Headache Drugs Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Migraine Headache Drugs Market Size (2018-2029) 10.2 Middle East & Africa Migraine Headache Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Migraine Headache Drugs Market Size by Country (2018-2023) 10.4 Middle East & Africa Migraine Headache Drugs Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Detail 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Migraine Headache Drugs Introduction 11.1.4 Pfizer Revenue in Migraine Headache Drugs Business (2018-2023) 11.1.5 Pfizer Recent Development 11.2 Novartis 11.2.1 Novartis Company Detail 11.2.2 Novartis Business Overview 11.2.3 Novartis Migraine Headache Drugs Introduction 11.2.4 Novartis Revenue in Migraine Headache Drugs Business (2018-2023) 11.2.5 Novartis Recent Development 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Company Detail 11.3.2 Johnson & Johnson Business Overview 11.3.3 Johnson & Johnson Migraine Headache Drugs Introduction 11.3.4 Johnson & Johnson Revenue in Migraine Headache Drugs Business (2018-2023) 11.3.5 Johnson & Johnson Recent Development 11.4 GSK 11.4.1 GSK Company Detail 11.4.2 GSK Business Overview 11.4.3 GSK Migraine Headache Drugs Introduction 11.4.4 GSK Revenue in Migraine Headache Drugs Business (2018-2023) 11.4.5 GSK Recent Development 11.5 Merck 11.5.1 Merck Company Detail 11.5.2 Merck Business Overview 11.5.3 Merck Migraine Headache Drugs Introduction 11.5.4 Merck Revenue in Migraine Headache Drugs Business (2018-2023) 11.5.5 Merck Recent Development 11.6 Eli Lilly 11.6.1 Eli Lilly Company Detail 11.6.2 Eli Lilly Business Overview 11.6.3 Eli Lilly Migraine Headache Drugs Introduction 11.6.4 Eli Lilly Revenue in Migraine Headache Drugs Business (2018-2023) 11.6.5 Eli Lilly Recent Development 11.7 Teva 11.7.1 Teva Company Detail 11.7.2 Teva Business Overview 11.7.3 Teva Migraine Headache Drugs Introduction 11.7.4 Teva Revenue in Migraine Headache Drugs Business (2018-2023) 11.7.5 Teva Recent Development 11.8 AstraZeneca 11.8.1 AstraZeneca Company Detail 11.8.2 AstraZeneca Business Overview 11.8.3 AstraZeneca Migraine Headache Drugs Introduction 11.8.4 AstraZeneca Revenue in Migraine Headache Drugs Business (2018-2023) 11.8.5 AstraZeneca Recent Development 11.9 Sun Pharma 11.9.1 Sun Pharma Company Detail 11.9.2 Sun Pharma Business Overview 11.9.3 Sun Pharma Migraine Headache Drugs Introduction 11.9.4 Sun Pharma Revenue in Migraine Headache Drugs Business (2018-2023) 11.9.5 Sun Pharma Recent Development 11.10 Grunenthal 11.10.1 Grunenthal Company Detail 11.10.2 Grunenthal Business Overview 11.10.3 Grunenthal Migraine Headache Drugs Introduction 11.10.4 Grunenthal Revenue in Migraine Headache Drugs Business (2018-2023) 11.10.5 Grunenthal Recent Development 11.11 Endo Pharmaceuticals 11.11.1 Endo Pharmaceuticals Company Detail 11.11.2 Endo Pharmaceuticals Business Overview 11.11.3 Endo Pharmaceuticals Migraine Headache Drugs Introduction 11.11.4 Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2018-2023) 11.11.5 Endo Pharmaceuticals Recent Development 11.12 Mylan 11.12.1 Mylan Company Detail 11.12.2 Mylan Business Overview 11.12.3 Mylan Migraine Headache Drugs Introduction 11.12.4 Mylan Revenue in Migraine Headache Drugs Business (2018-2023) 11.12.5 Mylan Recent Development 11.13 Bayer 11.13.1 Bayer Company Detail 11.13.2 Bayer Business Overview 11.13.3 Bayer Migraine Headache Drugs Introduction 11.13.4 Bayer Revenue in Migraine Headache Drugs Business (2018-2023) 11.13.5 Bayer Recent Development 11.14 Amneal Pharmaceuticals 11.14.1 Amneal Pharmaceuticals Company Detail 11.14.2 Amneal Pharmaceuticals Business Overview 11.14.3 Amneal Pharmaceuticals Migraine Headache Drugs Introduction 11.14.4 Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2018-2023) 11.14.5 Amneal Pharmaceuticals Recent Development 11.15 Apotex 11.15.1 Apotex Company Detail 11.15.2 Apotex Business Overview 11.15.3 Apotex Migraine Headache Drugs Introduction 11.15.4 Apotex Revenue in Migraine Headache Drugs Business (2018-2023) 11.15.5 Apotex Recent Development 11.16 Ajanta Pharma 11.16.1 Ajanta Pharma Company Detail 11.16.2 Ajanta Pharma Business Overview 11.16.3 Ajanta Pharma Migraine Headache Drugs Introduction 11.16.4 Ajanta Pharma Revenue in Migraine Headache Drugs Business (2018-2023) 11.16.5 Ajanta Pharma Recent Development 11.17 Allergan 11.17.1 Allergan Company Detail 11.17.2 Allergan Business Overview 11.17.3 Allergan Migraine Headache Drugs Introduction 11.17.4 Allergan Revenue in Migraine Headache Drugs Business (2018-2023) 11.17.5 Allergan Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Migraine Headache Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Almotriptan Table 3. Key Players of Eletriptan Table 4. Key Players of Sumatriptan Table 5. Key Players of Rizatriptan Table 6. Key Players of Zolmitriptan Table 7. Key Players of Naratriptan Table 8. Key Players of Frovatriptan Table 9. Key Players of Others Table 10. Global Migraine Headache Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 11. Global Migraine Headache Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 12. Global Migraine Headache Drugs Market Size by Region (2018-2023) & (US$ Million) Table 13. Global Migraine Headache Drugs Market Share by Region (2018-2023) Table 14. Global Migraine Headache Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 15. Global Migraine Headache Drugs Market Share by Region (2024-2029) Table 16. Migraine Headache Drugs Market Trends Table 17. Migraine Headache Drugs Market Drivers Table 18. Migraine Headache Drugs Market Challenges Table 19. Migraine Headache Drugs Market Restraints Table 20. Global Migraine Headache Drugs Revenue by Players (2018-2023) & (US$ Million) Table 21. Global Migraine Headache Drugs Market Share by Players (2018-2023) Table 22. Global Top Migraine Headache Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Headache Drugs as of 2022) Table 23. Ranking of Global Top Migraine Headache Drugs Companies by Revenue (US$ Million) in 2022 Table 24. Global 5 Largest Players Market Share by Migraine Headache Drugs Revenue (CR5 and HHI) & (2018-2023) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Migraine Headache Drugs Product Solution and Service Table 27. Date of Enter into Migraine Headache Drugs Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Migraine Headache Drugs Market Size by Type (2018-2023) & (US$ Million) Table 30. Global Migraine Headache Drugs Revenue Market Share by Type (2018-2023) Table 31. Global Migraine Headache Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 32. Global Migraine Headache Drugs Revenue Market Share by Type (2024-2029) Table 33. Global Migraine Headache Drugs Market Size by Application (2018-2023) & (US$ Million) Table 34. Global Migraine Headache Drugs Revenue Market Share by Application (2018-2023) Table 35. Global Migraine Headache Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 36. Global Migraine Headache Drugs Revenue Market Share by Application (2024-2029) Table 37. North America Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 38. North America Migraine Headache Drugs Market Size by Country (2018-2023) & (US$ Million) Table 39. North America Migraine Headache Drugs Market Size by Country (2024-2029) & (US$ Million) Table 40. Europe Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 41. Europe Migraine Headache Drugs Market Size by Country (2018-2023) & (US$ Million) Table 42. Europe Migraine Headache Drugs Market Size by Country (2024-2029) & (US$ Million) Table 43. Asia-Pacific Migraine Headache Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 44. Asia-Pacific Migraine Headache Drugs Market Size by Region (2018-2023) & (US$ Million) Table 45. Asia-Pacific Migraine Headache Drugs Market Size by Region (2024-2029) & (US$ Million) Table 46. Latin America Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 47. Latin America Migraine Headache Drugs Market Size by Country (2018-2023) & (US$ Million) Table 48. Latin America Migraine Headache Drugs Market Size by Country (2024-2029) & (US$ Million) Table 49. Middle East & Africa Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 50. Middle East & Africa Migraine Headache Drugs Market Size by Country (2018-2023) & (US$ Million) Table 51. Middle East & Africa Migraine Headache Drugs Market Size by Country (2024-2029) & (US$ Million) Table 52. Pfizer Company Detail Table 53. Pfizer Business Overview Table 54. Pfizer Migraine Headache Drugs Product Table 55. Pfizer Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 56. Pfizer Recent Development Table 57. Novartis Company Detail Table 58. Novartis Business Overview Table 59. Novartis Migraine Headache Drugs Product Table 60. Novartis Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 61. Novartis Recent Development Table 62. Johnson & Johnson Company Detail Table 63. Johnson & Johnson Business Overview Table 64. Johnson & Johnson Migraine Headache Drugs Product Table 65. Johnson & Johnson Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 66. Johnson & Johnson Recent Development Table 67. GSK Company Detail Table 68. GSK Business Overview Table 69. GSK Migraine Headache Drugs Product Table 70. GSK Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 71. GSK Recent Development Table 72. Merck Company Detail Table 73. Merck Business Overview Table 74. Merck Migraine Headache Drugs Product Table 75. Merck Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 76. Merck Recent Development Table 77. Eli Lilly Company Detail Table 78. Eli Lilly Business Overview Table 79. Eli Lilly Migraine Headache Drugs Product Table 80. Eli Lilly Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 81. Eli Lilly Recent Development Table 82. Teva Company Detail Table 83. Teva Business Overview Table 84. Teva Migraine Headache Drugs Product Table 85. Teva Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 86. Teva Recent Development Table 87. AstraZeneca Company Detail Table 88. AstraZeneca Business Overview Table 89. AstraZeneca Migraine Headache Drugs Product Table 90. AstraZeneca Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 91. AstraZeneca Recent Development Table 92. Sun Pharma Company Detail Table 93. Sun Pharma Business Overview Table 94. Sun Pharma Migraine Headache Drugs Product Table 95. Sun Pharma Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 96. Sun Pharma Recent Development Table 97. Grunenthal Company Detail Table 98. Grunenthal Business Overview Table 99. Grunenthal Migraine Headache Drugs Product Table 100. Grunenthal Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 101. Grunenthal Recent Development Table 102. Endo Pharmaceuticals Company Detail Table 103. Endo Pharmaceuticals Business Overview Table 104. Endo Pharmaceuticals Migraine Headache Drugs Product Table 105. Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 106. Endo Pharmaceuticals Recent Development Table 107. Mylan Company Detail Table 108. Mylan Business Overview Table 109. Mylan Migraine Headache Drugs Product Table 110. Mylan Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 111. Mylan Recent Development Table 112. Bayer Company Detail Table 113. Bayer Business Overview Table 114. Bayer Migraine Headache Drugs Product Table 115. Bayer Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 116. Bayer Recent Development Table 117. Amneal Pharmaceuticals Company Detail Table 118. Amneal Pharmaceuticals Business Overview Table 119. Amneal Pharmaceuticals Migraine Headache Drugs Product Table 120. Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 121. Amneal Pharmaceuticals Recent Development Table 122. Apotex Company Detail Table 123. Apotex Business Overview Table 124. Apotex Migraine Headache Drugs Product Table 125. Apotex Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 126. Apotex Recent Development Table 127. Ajanta Pharma Company Detail Table 128. Ajanta Pharma Business Overview Table 129. Ajanta Pharma Migraine Headache Drugs Product Table 130. Ajanta Pharma Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 131. Ajanta Pharma Recent Development Table 132. Allergan Company Detail Table 133. Allergan Business Overview Table 134. Allergan Migraine Headache Drugs Product Table 135. Allergan Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million) Table 136. Allergan Recent Development Table 137. Research Programs/Design for This Report Table 138. Key Data Information from Secondary Sources Table 139. Key Data Information from Primary Sources List of Figures Figure 1. Global Migraine Headache Drugs Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Migraine Headache Drugs Market Share by Type: 2022 VS 2029 Figure 3. Almotriptan Features Figure 4. Eletriptan Features Figure 5. Sumatriptan Features Figure 6. Rizatriptan Features Figure 7. Zolmitriptan Features Figure 8. Naratriptan Features Figure 9. Frovatriptan Features Figure 10. Others Features Figure 11. Global Migraine Headache Drugs Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 12. Global Migraine Headache Drugs Market Share by Application: 2022 VS 2029 Figure 13. Acute Migraine Case Studies Figure 14. Common Migraine Case Studies Figure 15. Classic Migraine Case Studies Figure 16. Chronic Migraine Case Studies Figure 17. Other Migraines Case Studies Figure 18. Migraine Headache Drugs Report Years Considered Figure 19. Global Migraine Headache Drugs Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 20. Global Migraine Headache Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 21. Global Migraine Headache Drugs Market Share by Region: 2022 VS 2029 Figure 22. Global Migraine Headache Drugs Market Share by Players in 2022 Figure 23. Global Top Migraine Headache Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Headache Drugs as of 2022) Figure 24. The Top 10 and 5 Players Market Share by Migraine Headache Drugs Revenue in 2022 Figure 25. North America Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. North America Migraine Headache Drugs Market Share by Country (2018-2029) Figure 27. United States Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Canada Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Europe Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Europe Migraine Headache Drugs Market Share by Country (2018-2029) Figure 31. Germany Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. France Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. U.K. Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Italy Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. Russia Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Nordic Countries Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Asia-Pacific Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Asia-Pacific Migraine Headache Drugs Market Share by Region (2018-2029) Figure 39. China Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Japan Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. South Korea Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Southeast Asia Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. India Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Australia Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Latin America Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Latin America Migraine Headache Drugs Market Share by Country (2018-2029) Figure 47. Mexico Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 48. Brazil Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 49. Middle East & Africa Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 50. Middle East & Africa Migraine Headache Drugs Market Share by Country (2018-2029) Figure 51. Turkey Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 52. Saudi Arabia Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 53. Pfizer Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 54. Novartis Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 55. Johnson & Johnson Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 56. GSK Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 57. Merck Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 58. Eli Lilly Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 59. Teva Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 60. AstraZeneca Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 61. Sun Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 62. Grunenthal Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 63. Endo Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 64. Mylan Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 65. Bayer Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 66. Amneal Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 67. Apotex Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 68. Ajanta Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 69. Allergan Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Pfizer Novartis Johnson & Johnson GSK Merck Eli Lilly Teva AstraZeneca Sun Pharma Grunenthal Endo Pharmaceuticals Mylan Bayer Amneal Pharmaceuticals Apotex Ajanta Pharma Allergan